Which hedge funds own RIGL? RIGEL PHARMACEUTICALS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in RIGL (RIGEL PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $46.9m in total. The largest holder by portfolio weight is D. E. Shaw & Co at 0.0% of its book. 1 exited: Brevan Howard Capital Management.
5tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold RIGL? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co | Q2 2026 | 0.0% | $21.2m | 542,539 | 22% | added |
| Marshall Wace | Q2 2026 | 0.0% | $14.4m | 367,393 | -39% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $5.7m | 145,846 | -57% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $2.0m | 50,000 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $3.7m | 93,689 | -65% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $353.4k |
How has hedge fund ownership of RIGL changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $46.9m |
| Q1 2026 | 7 | $49.8m |
| Q4 2025 | 2 | $25.2m |
| Q3 2025 | 1 | $13.4m |
| Q2 2025 | 1 | $4.4m |
| Q1 2025 | 1 | $3.6m |
| Q4 2024 | 1 | $5.0m |
| Q3 2024 | 1 | $2.3m |
| Q2 2024 | 1 | $1.2m |
| Q1 2024 | 1 | $3.0m |
| Q4 2023 | 1 | $1.9m |
| Q3 2023 | 1 | $1.2m |
| Q2 2023 | 1 | $2.0m |
| Q1 2023 | 2 | $2.6m |
| Q4 2022 | 1 | $1.2m |
| Q3 2022 | 1 | $1.5m |
Counts every tracked manager that disclosed RIGL in that quarter's filing, including managers that have since stopped filing.